Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis

Osteoarthritis and Cartilage

Volumn 14, Issue 11, 2006, Pages 1155-1162

  Schuelert, N ^a   McDougall, J J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Animal model; Electrophysiological recordings; Knee joint nerves; Neuropeptides; Osteoarthritis; Pain

Indexed keywords

UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE[6-28];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; KNEE FUNCTION; KNEE OSTEOARTHRITIS; MALE; NOCICEPTION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RAT STRAIN; SENSITIZATION; SENSORY NERVE; SENSORY SYSTEM ELECTROPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HINDLIMB; INJECTIONS, INTRA-ARTERIAL; JOINTS; MALE; MOVEMENT; NERVE FIBERS; NEURONS, AFFERENT; OSTEOARTHRITIS; PAIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; ROTATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33749340590     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.04.016     Document Type: Article

References (40)

1. Schaible H.G., and Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain 55 1 (1993) 5-54
2. Schaible H.G., and Schmidt R.F. Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 54 5 (1985) 1109-1122
3. Heppelmann B., and Pawlak M. Sensitisation of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci Lett 223 2 (1997) 97-100
4. McDougall J.J., Hanesch U., Pawlak M., and Schmidt R.F. Participation of NK1 receptors in nociceptin-induced modulation of rat knee joint mechanosensitivity. Exp Brain Res 137 2 (2001) 249-253
5. McDougall J.J., Pawlak M., Hanesch U., and Schmidt R.F. Peripheral modulation of rat knee joint afferent mechanosensitivity by nociceptin/orphanin FQ. Neurosci Lett 288 2 (2000) 123-126
6. Ahmed M., Bjurholm A., Theodorsson E., Schultzberg M., and Kreicbergs A. Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment. Neuropeptides 29 1 (1995) 33-43
7. Abramovici A., Daizade I., Yosipovitch Z., Gibson S.J., and Polak J.M. The distribution of peptide-containing nerves in the synovia of the cat knee joint. Histol Histopathol 6 4 (1991) 469-476
8. Catre M.G., and Salo P.T. Quantitative analysis of the sympathetic innervation of the rat knee joint. J Anat 194 Pt 2 (1999) 233-239
9. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 2 (1998) 265-270
10. Dickinson T., and Fleetwood-Walker S.M. VIP and PACAP: very important in pain?. Trends Pharmacol Sci 20 8 (1999) 324-329
11. McDougall J.J., and Barin A.K. The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats. Br J Pharmacol 145 1 (2005) 104-113
12. Li Z., Proud D., Zhang C., Wiehler S., and McDougall J.J. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception. Arthritis Rheum 52 10 (2005) 3210-3219
13. Gencosmanoglu B.E., Eryavuz M., and Dervisoglu S. Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res Exp Med (Berl) 200 3 (2001) 215-226
14. Guingamp C., Gegout-Pottie P., Philippe L., Terlain B., Netter P., and Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 40 9 (1997) 1670-1679
15. Janusz M.J., Hookfin E.B., Heitmeyer S.A., Woessner J.F., Freemont A.J., Hoyland J.A., et al. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage 9 8 (2001) 751-760
16. Kalbhen D.A. Chemical model of osteoarthritis - a pharmacological evaluation. J Rheumatol 14 Spec No (1987) 130-131
17. Just S., Pawlak M., and Heppelmann B. Responses of fine primary afferent nerve fibres innervating the rat knee joint to defined torque. J Neurosci Methods 103 2 (2000) 157-162
18. Bove S.E., Calcaterra S.L., Brooker R.M., Huber C.M., Guzman R.E., Juneau P.L., et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthrtits Cartilage 11 11 (2003) 821-830
19. McDougall JJ, Watkins L, Li Z. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain (In press).
20. Schaible H.G., and Schmidt R.F. Activation of groups III and IV sensory units in medial articular nerve by local mechanical stimulation of knee joint. J Neurophysiol 49 1 (1983) 35-44
21. Pawlak M., Schmidt R.F., Heppelmann B., and Hanesch U. The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat. Eur J Pain 5 1 (2001) 69-79
22. Heppelmann B., Just S., and Pawlak M. Galanin influences the mechanosensitivity of sensory endings in the rat knee joint. Eur J Neurosci 12 5 (2000) 1567-1572
23. Jeftinija S., Murase K., Nedeljkov V., and Randic M. Vasoactive intestinal polypeptide excites mammalian dorsal horn neurons both in vivo and in vitro. Brain Res 243 1 (1982) 158-164
24. Dickinson T., Fleetwood-Walker S.M., Mitchell R., and Lutz E.M. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Neuropeptides 31 2 (1997) 175-185
25. Dickinson T., Mitchell R., Robberecht P., and Fleetwood-Walker S.M. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology 38 1 (1999) 167-180
26. Taiwo Y.O., and Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44 1 (1991) 131-135
27. Taiwo Y.O., Heller P.H., and Levine J.D. Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience 48 2 (1992) 479-483
28. Zhang Q., Shi T.J., Ji R.R., Zhang Y.Z., Sundler F., Hannibal J., et al. Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res 705 1-2 (1995) 149-158
29. Zhang X., Bean A.J., Wiesenfeld-Hallin Z., and Hokfelt T. Ultrastructural studies on peptides in the dorsal horn of the rat spinal cord - IV. Effects of peripheral axotomy with special reference to neuropeptide Y and vasoactive intestinal polypeptide/peptide histidine isoleucine. Neuroscience 64 4 (1995) 917-941
30. Villar M.J., Cortes R., Theodorsson E., Wiesenfeld-Hallin Z., Schalling M., Fahrenkrug J., et al. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 33 3 (1989) 587-604
31. Nahin R.L., Ren K., De Leon M., and Ruda M. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain 58 1 (1994) 95-108
32. Combe R., Bramwell S., and Field M.J. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?. Neurosci Lett 370 2-3 (2004) 236-240
33. Coggeshall R.E., Hong K.A., Langford L.A., Schaible H.G., and Schmidt R.F. Discharge characteristics of fine medial articular afferents at rest and during passive movements of inflamed knee joints. Brain Res 272 1 (1983) 185-188
34. Schaible H.G., and Schmidt R.F. Time course of mechanosensitivity changes in articular afferents during a developing experimental arthritis. J Neurophysiol 60 6 (1988) 2180-2195
35. Grigg P., Schaible H.G., and Schmidt R.F. Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee. J Neurophysiol 55 4 (1986) 635-643
36. Lygren I., Ostensen M., Burhol P.G., and Husby G. Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease. Ann Rheum Dis 45 8 (1986) 637-640
37. Hernanz A., Medina S., de Miguel E., and Martin-Mola E. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regul Pept 115 1 (2003) 19-24
38. Delgado M., Abad C., Martinez C., Juarranz M.G., Arranz A., Gomariz R.P., et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 80 1 (2002) 16-24
39. Niissalo S., Hukkanen M., Imai S., Tornwall J., and Konttinen Y.T. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci 966 (2002) 384-399
40. Juarranz M.G., Santiago B., Torroba M., Gutierrez-Canas I., Palao G., Galindo M., et al. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells. Rheumatology (Oxford) 43 4 (2004) 416-422